Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Natural Antibodies Can Prevent Adverse Immune Reactions

By LabMedica International staff writers
Posted on 11 Mar 2019
Natural antibodies, in particular IgG, have been shown to be a critical factor that determines the efficiency of complement activation in different subjects and by different nanomaterials.

Deposition of complement factors (opsonization) on nanoparticles may promote clearance from the blood by macrophages and trigger pro-inflammatory responses, but the mechanisms regulating the efficiency of complement activation are poorly understood.

Opsonization is the molecular mechanism whereby molecules, microbes, or apoptotic cells are chemically modified to have stronger interactions with cell surface receptors on phagocytes and natural killer (NK cells). More...
With the antigen coated in opsonins, binding to immune cells is greatly enhanced. Opsonization also mediates phagocytosis via signal cascades from cell surface receptors. Opsonins aid the immune system in a number of ways: in a healthy individual, they mark dead and dying self-cells for clearance by macrophages and neutrophils, activate complement proteins, and target cells for destruction through the action of NK cells.

Investigators at the University of Colorado (Aurora, CO, USA) previously found that opsonization of superparamagnetic iron oxide (SPIO) nanoworms with the third complement protein (C3) was dependent on the biomolecule corona of the nanoparticles. C3 is a molecule that plays a central role in the activation of the complement system, and its activation is required for both classical and alternative complement activation pathways. People with C3 deficiency are susceptible to bacterial infection.

In a paper published in the January 14, 2019, online edition of the journal Nature Nanotechnology, the investigators reported that binding of only a few immunoglobulin molecules, and specifically IgG, determined the efficiency of C3 deposition on nanomaterials introduced into the plasma and sera of healthy donors and in plasma of cancer patients, regardless of the complement activation pathway. Moreover, the presence of the biomolecule corona enhanced IgG binding to all tested nanomaterials.

“In all of the nanoparticles that we tested, complement activation was dependent on the binding of certain of these natural antibodies to nanoparticles,” said senior author Dr. Dmitri Simberg, associate professor of pharmaceutical sciences at the University of Colorado. “Interestingly, the antibodies bind to the proteins in the corona, rather than to the pristine nanoparticle surface itself. If a person has a high level of antibodies that can recognize a particular type of nanoparticle, this person will have high complement activation. The study gave us an exciting new angle on how the system recognizes nanomaterials. This knowledge step is important for designing a better coating so the particles can be more biocompatible and safer. I am a really big fan and proponent of mechanistic studies in the nanodrug delivery field that can guide us to better designs.”

Related Links:
University of Colorado


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Portable Electronic Pipette
Mini 96
New
Gold Member
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.